Document is current
Any future updates will be listed below
-
Authors
Wu, Yukang
Li, Jianguo
Feng, Ke
Tan, Ailing
Gao, Yingying
Chen, Wen
Jia, Wenwen
Guo, Xudong
Kang, Jiuhong https://orcid.org/0000-0001-7538-1889
-
Funding
Funding for this research was provided by:
Key Technologies Research and Development Program (2021YFA1100400)
National Natural Science Foundation of China (82271723, 82071728, 32170575)
Natural Science Foundation of Shanghai Municipality (23ZR1465500)
Fundamental Research Funds for the Central Universities (22120220620)
- License Information
-
More Information
Article History
Received: 27 June 2024
Accepted: 30 October 2024
First Online: 13 November 2024
Declarations
:
: This study was approved by the Animal Experimentation Ethics Committee, Tongji University [TJABO4523102 (title: The functions and mechanisms of N-CADHERIN<sup>+</sup>/CD168<sup>−</sup> umbilical cord mesenchymal stem cell subpopulation in the treatment of myocardial infarction; date:28 <sup>th</sup> Feb, 2023)] and approved by the Institutional Animal Care and Use Committee of Tongji University. Human umbilical cord mesenchymal stem cells were obtained following signed informed consent and approved for the project: The preparation and construction of clinical human umbilical cord and umbilical cord blood stem cells, the Ethics Committee of Shanghai East Hospital (No: 2017 Preliminary Review No. (001)). 18th Oct. 2019.
: Not applicable.
: Authors declare that they have no competing interests.
